This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.


Mantle Cell Lymphoma Research Initiative II – Synergistic Team Award (worldwide)


The Mantle Cell Lymphoma Research Initiative II – Synergistic Team Award funded by the Leukemia and Lymphoma Society (LLS) supports targeted research to better understand disease mechanisms, develop more efficacious treatments and improve the outcome for MCL patients. This program is primarily focused on relapsed disease. However, novel work focused on early disease intervention or improved risk stratification is of interest. LLS calls for the submission of creative proposals with the potential for high impact in MCL. Applications should address both transformative issues in MCL biology and promising new directions in MCL therapy.

The Synergistic Team Award (STA) will support substantial, collaborative projects addressing a significant obstacle in understanding and treating MCL. Applications are open to researchers worldwide at reputable academic research institutions. Applicants may apply for up to 3 million USD in funding over 4 years, including 10% indirect costs.

Letters of intent are due by December 5, 2022. Full applications close on February 24, 2023.

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts


Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.